| A global view of hepatocellular carcinoma: trends, risk, prevention and management JD Yang, P Hainaut, GJ Gores, A Amadou, A Plymoth, LR Roberts Nature reviews Gastroenterology & hepatology 16 (10), 589-604, 2019 | 2324 | 2019 |
| Hepatocellular carcinoma: a global view JD Yang, LR Roberts Nature reviews Gastroenterology & hepatology 7 (8), 448-458, 2010 | 1496 | 2010 |
| Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles F Farshidfar, S Zheng, MC Gingras, Y Newton, J Shih, AG Robertson, ... Cell reports 18 (11), 2780-2794, 2017 | 543 | 2017 |
| The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets JD Yang, I Nakamura, LR Roberts Seminars in cancer biology 21 (1), 35-43, 2011 | 430 | 2011 |
| Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma JD Yang, WR Kim, R Coelho, TA Mettler, JT Benson, SO Sanderson, ... Clinical Gastroenterology and Hepatology 9 (1), 64-70, 2011 | 296 | 2011 |
| Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis JD Yang, MF Abdelmalek, H Pang, CD Guy, AD Smith, AM Diehl, ... Hepatology 59 (4), 1406-1414, 2014 | 287 | 2014 |
| Epidemiology and management of hepatocellular carcinoma JD Yang, LR Roberts Infectious Disease Clinics 24 (4), 899-919, 2010 | 236 | 2010 |
| New advances in the diagnosis and management of hepatocellular carcinoma JD Yang, JK Heimbach Bmj 371, 2020 | 187 | 2020 |
| Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium JD Yang, EA Mohamed, AOA Aziz, HI Shousha, MB Hashem, MM Nabeel, ... The lancet Gastroenterology & hepatology 2 (2), 103-111, 2017 | 184 | 2017 |
| Detection of circulating tumor cells and their implications as a biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma JC Ahn, PC Teng, PJ Chen, E Posadas, HR Tseng, SC Lu, JD Yang Hepatology 73 (1), 422-436, 2021 | 161 | 2021 |
| Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk R Chaiteerakij, JD Yang, WS Harmsen, SW Slettedahl, TA Mettler, ... Hepatology 57 (2), 648-655, 2013 | 156 | 2013 |
| Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma LE Moreno-Luna, JD Yang, W Sanchez, R Paz-Fumagalli, DM Harnois, ... Cardiovascular and interventional radiology 36, 714-723, 2013 | 149 | 2013 |
| Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS‐HCC risk model JA Flemming, JD Yang, E Vittinghoff, WR Kim, NA Terrault Cancer 120 (22), 3485-3493, 2014 | 145 | 2014 |
| Factors that affect risk for hepatocellular carcinoma and effects of surveillance JD Yang, WS Harmsen, SW Slettedahl, R Chaiteerakij, FT Enders, ... Clinical Gastroenterology and Hepatology 9 (7), 617-623. e1, 2011 | 143 | 2011 |
| A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease JS Klair, JD Yang, MF Abdelmalek, CD Guy, RM Gill, K Yates, ... Hepatology 64 (1), 85-91, 2016 | 142 | 2016 |
| Neuropilin-1 Stimulates Tumor Growth by Increasing Fibronectin Fibril Assembly in the Tumor MicroenvironmentNeuropilin, Fibronectin, and Tumor Growth U Yaqoob, S Cao, U Shergill, K Jagavelu, Z Geng, M Yin, ... Cancer research 72 (16), 4047-4059, 2012 | 142 | 2012 |
| Diabetes is associated with increased risk of hepatocellular carcinoma in patients with cirrhosis from nonalcoholic fatty liver disease JD Yang, F Ahmed, KC Mara, BD Addissie, AM Allen, GJ Gores, ... Hepatology 71 (3), 907-916, 2020 | 129 | 2020 |
| Hepatocellular carcinoma is the most common indication for liver transplantation and placement on the waitlist in the United States JD Yang, JJ Larson, KD Watt, AM Allen, RH Wiesner, GJ Gores, ... Clinical Gastroenterology and Hepatology 15 (5), 767-775. e3, 2017 | 129 | 2017 |
| GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS ScoreGALAD, GALADUS for HCC Detection JD Yang, BD Addissie, KC Mara, WS Harmsen, J Dai, N Zhang, ... Cancer Epidemiology, Biomarkers & Prevention 28 (3), 531-538, 2019 | 119 | 2019 |
| Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring N Sun, YT Lee, RY Zhang, R Kao, PC Teng, Y Yang, P Yang, JJ Wang, ... Nature communications 11 (1), 4489, 2020 | 103 | 2020 |
